Hours
Shelf life for many radiopharmaceuticals
Life Sciences · Radiopharmaceuticals
Radiopharmaceuticals have no inventory buffer. Half-lives measured in hours mean every dose is a just-in-time manufacturing event — and every write-off is immediate. Archer configures NetSuite to give radiopharmaceutical organizations the financial and operational control that decay physics demand.
Hours
Shelf life for many radiopharmaceuticals
$11.85B
Global radiopharma market, 2024
11.45%
Sector CAGR through 2034
Zero
Inventory buffer possible
Multi-site
Production & distribution required
When your product decays whether or not it reaches the patient, every inefficiency in your supply chain, financial system, and reporting process has a direct dollar cost. Isotope shortages, specialized infrastructure, and site-specific distribution add layers of complexity that standard inventory and manufacturing ERP simply wasn't designed to handle.
Standard FIFO inventory logic assumes product stays on the shelf until it's used. Radiopharmaceuticals don't. Real-time lot expiration tracking, automated write-offs at decay thresholds, and cost accounting that reflects actual usable product require configurations that most ERP implementations have never attempted.
A 6-hour half-life means unsold inventory becomes a write-off before the business day ends
Cyclotron facilities, regional dose preparation centers, and hospital delivery nodes each require their own inventory, cost, and compliance tracking — while leadership needs consolidated financials that eliminate intercompany activity without a week of manual work.
Sites across geographies multiply close complexity by the number of entities in the network
NRC requirements demand documented chain of custody at every transfer point — from isotope production through patient administration. When financial and compliance documentation systems are separate, the reconciliation burden falls on finance teams during every close.
Isotope shortage events in 2024–2025 made supply chain documentation failures acutely costly
Cyclotrons, hot cells, and specialized shielding represent significant fixed asset investments. Understanding depreciation, maintenance cost, and asset-level contribution to margin requires fixed asset management integrated with your production and financial data.
Companies must invest in manufacturing capacity well before regulatory approval — making capital allocation clarity essential
Archer configures NetSuite with expiration-aware lot tracking, multi-site financial consolidation, and compliance documentation workflows that match the operating reality of radiopharmaceutical manufacturing and distribution.
Archer Module
Bi-directional integration with specialized radiopharmaceutical logistics partners and hospital delivery networks — with real-time shipment confirmation, dose-level tracking, and delivery documentation tied directly to financial records.
Archer Module
Configurable approval routing for high-value isotope procurement, capital equipment, and site-level operating expenditures — with audit trails that document every authorization decision across a distributed production network.
Archer Module
AI-powered extraction and coding of supplier, logistics, and site service invoices — reducing manual AP processing time while maintaining the cost-center precision required for accurate site-level margin reporting.
Archer Module
FDA-compliant electronic signatures across financial and operational approvals — supporting the documented authorization chain that radioactive material handling and regulatory compliance require at every step.
When inventory accounting, compliance documentation, and multi-site consolidation are built into your ERP — rather than managed around it — the administrative burden of running a radiopharmaceutical operation shrinks significantly.
Real-time
Lot expiration visibility
Expiration-aware lot tracking with automated accounting entries means inventory valuation is always current — no manual adjustments at close, no surprises when auditors ask how you account for radioactive decay.
One
Consolidated view across all sites
Each production and distribution site tracked as a distinct entity with consolidated P&L, intercompany eliminations, and site-level margin reporting — generated from NetSuite, not assembled from site-level spreadsheets.
Faster
Capital allocation decisions
Cyclotrons, hot cells, and specialized equipment tracked with depreciation schedules, maintenance cost history, and production-linked utilization data — giving leadership the asset-level visibility needed for major capital decisions.
Get started
Schedule a discovery call with Archer. We'll assess your current environment and show you what purpose-built NetSuite configuration looks like for radiopharmaceutical organizations.